-
公开(公告)号：EP3143160A1
公开(公告)日：2017-03-22
申请号：EP15727137.0
申请日：2015-05-13
发明人： STONE, Steven , GUTIN, Alexander , REID, Julia
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/118 , C12Q2600/158
摘要： Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
摘要翻译： 提供了使用生物标志物在患者中分类癌症的生物标志物和方法（例如，预测癌症特异性死亡或癌症复发的风险）。
-
公开(公告)号：EP3118328A1
公开(公告)日：2017-01-18
申请号：EP16170659.3
申请日：2010-01-07
发明人： STONE, Steve , GUTIN, Alexander , WAGNER, Susanne , REID, Jutta
IPC分类号： C12Q1/68 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/118 , C12Q2600/154 , C12Q2600/158 , C12Q2600/178 , G01N33/574 , G01N2800/56
摘要： Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
摘要翻译： 提供了使用生物标志物预测患者癌症复发风险的生物标志物和方法。
-
公开(公告)号：EP2920322A1
公开(公告)日：2015-09-23
申请号：EP13795976.3
申请日：2013-11-15
发明人： STONE, Steven , GUTIN, Alexander , WAGNER, Susanne , REID, Julia
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/118 , C12Q2600/158
摘要： Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
-
公开(公告)号：EP2794907A1
公开(公告)日：2014-10-29
申请号：EP12860530.0
申请日：2012-12-21
申请人： Myriad Genetics, Inc. , Abkevich, Victor , Gutin, Alexander , Timms, Kirsten , Lanchbury, Jerry
摘要： This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号：EP2438197A2
公开(公告)日：2012-04-11
申请号：EP10784236.1
申请日：2010-06-07
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/112 , C12Q2600/156 , C12Q2600/16 , G06F19/20
摘要： Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided.
-
公开(公告)号：EP4234711A3
公开(公告)日：2023-09-20
申请号：EP23160447.1
申请日：2015-08-17
IPC分类号： C12Q1/68 , A61P35/00 , C12Q1/6886
摘要： This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of homologous recombination deficiency (HRD) or an HRD signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an HRD signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号：EP4139490A2
公开(公告)日：2023-03-01
申请号：EP21792913.2
申请日：2021-04-16
IPC分类号： C12Q1/6886 , C12Q1/6809 , G01N37/00 , C12M1/34
-
公开(公告)号：EP3812469A1
公开(公告)日：2021-04-28
申请号：EP20210783.5
申请日：2011-07-07
发明人： STONE, Steven , GUTIN, Alexander , WAGNER, Susanne , REID, Julia
摘要： Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
-
19.发明公开
公开(公告)号：EP3679160A2
公开(公告)日：2020-07-15
申请号：EP18853890.4
申请日：2018-09-07
IPC分类号： C12Q1/6886 , G16B20/00 , G16H50/00
-
公开(公告)号：EP3012329B1
公开(公告)日：2017-10-25
申请号：EP15189527.3
申请日：2011-06-17
CPC分类号： C12Q1/6886 , C12Q1/6827 , C12Q2600/106 , C12Q2600/136 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G06F19/18 , C12Q2537/16
-
-
-
-
-
-
-
-
-
搜索结果
52 条记录 (耗时 0.032 秒)
